Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 1.00 |
| ▸ | BCHE | P06276 | 10/20 | 1.00 |
| ▸ | FAAH | O00519 | 1/20 | 0.83 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.83 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.83 |
| ▸ | PDE5A | O76074 | 1/20 | 0.83 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.83 |
| ▸ | APP | P05067 | 1/20 | 0.83 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.83 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.83 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.83 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.83 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.83 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.83 |
| ▸ | DRD4 | P21917 | 1/20 | 0.83 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.83 |
| ▸ | MAOB | P27338 | 1/20 | 0.83 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.83 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13854659 | 0.93 | ACHE (0.87) | ACHEBCHEFAAHABCC4CACNA1F | |
| SCHEMBL2615347 | 0.92 | ACHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| SCHEMBL13284566 | 0.91 | ACHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| SCHEMBL12375152 | 0.91 | ACHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| SCHEMBL13854750 | 0.91 | ACHE (0.83) | ACHEBCHEFAAHABCC4CACNA1F | |
| Donepezil SCHEMBL12043710 | 0.91 | BCHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| Donepezil SCHEMBL3851203 | 0.91 | BCHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| Donepezil SCHEMBL8265876 | 0.91 | BCHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| Donepezil SCHEMBL2149 | 0.91 | BCHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F | |
| Donepezil SCHEMBL3516 | 0.91 | BCHE (1.00) | ACHEBCHEFAAHABCC4CACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994328-B2 | Process for the preparation of donepezil hydrochloride | AUROBINDO PHARMA LTD. (IN) | 2011-08-09 | — | — | US | disclosed |
| US-20100311793-A1 | POLYMORPHS OF DONEPEZIL SALTS, PREPARATION METHODS AND USES THEREOF | TIANJIN HEMAY BIO-TECH CO., LTD (CN) | 2010-12-09 | — | — | US | disclosed |
| US-7446203-B2 | Preparation of intermediates for acetycholinesterase inhibitors | HETERO DRUGS LIMITED (IN) | 2008-11-04 | — | — | US | disclosed |
| US-20070191610-A1 | Process for the preparation of donepezil hydrochloride | AUROBINDO PHARMA LTD (IN) | 2007-08-16 | — | — | US | disclosed |
| US-20070021397-A1 | Neurocyte protective agent | EISAI CO., LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191610-A1 | Process for the preparation of donepezil hydrochloride | CHRNA5, QDPR, ACHE | ACHE 3/4885BCHE 7/4885FAAH 1288/4885 |
| US-20070021397-A1 | Neurocyte protective agent | CHAT, GAP43, NES | ACHE 6/4885BCHE 26/4885FAAH 704/4885 |
| US-20100311793-A1 | POLYMORPHS OF DONEPEZIL SALTS, PREPARATION METHODS AND USES THEREOF | ME1, SDHA, GLS | ACHE 386/4885BCHE 377/4885FAAH 3000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.